From Disease to Pregnancy: Rethinking Cardiac Remodeling Through Fibroblast, Immune Cell, and Hormonal Interactions
Preprint
- 2 April 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Cardiac fibrosis is a central determinant of heart failure progression and arises from pathological remodeling characterized by fibroblast activation, myofibroblast differentiation, and excessive extracellular matrix deposition. In contrast, physiological remodeling permits adaptive cardiac growth without net fibrosis. Pregnancy represents an underexplored physiological model of reversible cardiac remodeling. In response to hemodynamic load, the maternal heart undergoes hypertrophic growth that resolves postpartum, constituting a natural paradigm of fibrosis-resistant cardiac adaptation. Pregnancy and lactation are accompanied by profound endocrine and immune reprogramming of maternal tissues. We propose that this hormonal milieu orchestrates coordinated crosstalk among endothelial cells, fibroblasts, and immune cell populations to suppress profibrotic pathways and preserve extracellular matrix homeostasis. Candidate regulators include estrogen, progesterone, prolactin family peptides, relaxin, oxytocin, and components of the renin–angiotensin–aldosterone system. During the postpartum and lactational period, prolactin and oxytocin may further promote reverse remodeling. These hormones likely act by modulating local cytokine and growth factor networks that otherwise drive fibroblast activation. By focusing on non-myocyte cardiac cells and extracellular matrix dynamics, this review positions pregnancy as a translational model to uncover endogenous anti-fibrotic mechanisms and identify novel therapeutic strategies for cardiac fibrosis.Keywords
All Related Versions
- Version 1, 2026-04-02, Preprints
- Published version: Cells, 15 (9), 778.
This publication has 125 references indexed in Scilit:
- The heterocellular heart: identities, interactions, and implications for cardiologyBasic Research in Cardiology, 2023
- Primary aldosteronism in pregnancyReviews in Endocrine and Metabolic Disorders, 2022
- Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?Clinical Rheumatology, 2019
- Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunctionClinical Research in Cardiology, 2018
- Right Ventricular Dysfunction in Left-Sided Heart Failure with Preserved Versus Reduced Ejection FractionEuropean Journal of Heart Failure, 2017
- Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathyBasic Research in Cardiology, 2015
- The pathogenesis of cardiac fibrosisCellular and Molecular Life Sciences, 2013
- The myofibroblast matrix: implications for tissue repair and fibrosisThe Journal of Pathology, 2012
- Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletesNetherlands Heart Journal, 2008
- Nitric-Oxide-Dependent Pial Arteriolar Dilation in the Female Rat: Effects of Chronic Estrogen Depletion and RepletionBiochemical and Biophysical Research Communications, 2000